APA (7th ed.) Citation

Whitehead, S. S., Durbin, A. P., Pierce, K. K., Elwood, D., McElvany, B. D., Fraser, E. A., . . . Kirkpatrick, B. D. (2017). In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. PLoS neglected tropical diseases, 11(5), e0005584. https://doi.org/10.1371/journal.pntd.0005584

Chicago Style (17th ed.) Citation

Whitehead, Stephen S., et al. "In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects with Flavivirus Exposure Prior to Vaccination." PLoS Neglected Tropical Diseases 11, no. 5 (2017): e0005584. https://doi.org/10.1371/journal.pntd.0005584.

MLA (9th ed.) Citation

Whitehead, Stephen S., et al. "In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects with Flavivirus Exposure Prior to Vaccination." PLoS Neglected Tropical Diseases, vol. 11, no. 5, 2017, p. e0005584, https://doi.org/10.1371/journal.pntd.0005584.